[6]-Gingerol dampens hepatic steatosis and inflammation in experimental nonalcoholic steatohepatitis

This publication has 31 references indexed in Scilit:

• Attenuation of Proinflammatory Responses byS-[6]-Gingerol via Inhibition of ROS/NF-Kappa B/COX2 Activation in HuH7 Cells
  Evidence-Based Complementary and Alternative Medicine, 2013
• Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease - A historical prospective
  Lipids in Health and Disease, 2013
• Absence of Genotoxic and Mutagenic Effects ofZingiber zerumbet(L.) Smith (Zingiberaceae) Extract
  Evidence-Based Complementary and Alternative Medicine, 2012
• Zingiber zerumbet (L.) Smith: A Review of Its Ethnomedicinal, Chemical, and Pharmacological Uses
  Evidence-Based Complementary and Alternative Medicine, 2011
• Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
  Digestive Diseases and Sciences, 2009
• VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice†
  Hepatology, 2009
• [6]-Gingerol prevents UVB-induced ROS production and COX-2 expressionin vitroandin vivo
  Free Radical Research, 2007
• MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
  Journal of Clinical Investigation, 2006
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
  Hepatology, 2005
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001